A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines 1 1Edited by A. R. Fersht
- 1 May 2000
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 299 (1), 245-253
- https://doi.org/10.1006/jmbi.2000.3738
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6Molecular and Cellular Biology, 1998
- E1A signaling to p53 involves the p19ARFtumor suppressorGenes & Development, 1998
- The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2Oncogene, 1998
- Synergistic activation of p53 by inhibition of MDM2 expression and DNA damageProceedings of the National Academy of Sciences, 1998
- Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivoCurrent Biology, 1997
- Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2Oncogene, 1997
- Activation of CPP32 and Mch3α in wild-type p53-induced apoptosisBiochemical Journal, 1997
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Mapping of the p53 and mdm-2 interaction domains.Molecular and Cellular Biology, 1993
- p53 functions as a cell cycle control protein in osteosarcomas.Molecular and Cellular Biology, 1990